Physical and functional relationships provide different kinds of evidence. A physical relationship indicates that proteins bind or are recovered together, whereas a functional relationship links proteins through shared biological evidence without necessarily demonstrating direct contact. Keeping these categories distinct helps researchers interpret network edges appropriately and avoid treating every connection as proof of a direct molecular complex.
Each detection strategy samples a different aspect of protein connectivity. Yeast two-hybrid assays test protein pairing, affinity purification with mass spectrometry identifies proteins that co-purify, and proximity labeling records proteins found near a selected target. Computational analysis can integrate these results with shared biological evidence, producing a more informative map than relying on one experimental readout.
Experimental methods produce different forms of evidence, so computational analysis helps organize them into an interaction network. It can bring together binding, co-purification, proximity, and shared biological relationships, allowing researchers to examine pathways, complexes, and regulatory hubs in one framework. This integration is especially useful when a cellular response involves many proteins rather than a single pair.
A study can begin by selecting proteins or a biological process, then applying an assay suited to the relationship being investigated. Researchers collect interaction evidence, characterize the detected connections, and use computational analysis to organize them into a network. The resulting map can then be examined for complexes, pathways, regulatory hubs, or changes under stress or disease.
In cell biology, these maps help connect individual proteins to larger signaling pathways, protein complexes, and gene-regulatory systems. They also provide a framework for examining how cells respond to stress. By viewing relationships as networks rather than isolated pairings, researchers can identify coordinated cellular processes and generate hypotheses about the roles of proteins whose functions are not fully characterized.
Comparing interaction networks across healthy and disease-related contexts can reveal network changes associated with disease. These changes may highlight regulatory hubs or disrupted relationships that merit experimental study. The same information can guide validation of potential therapeutic targets, providing a basis for prioritizing and testing candidates rather than replacing direct biological validation.